print small

Participating Countries:

Algeria

Argentina

Australia

Austria

Belgium

Bosnia and Herzegovina

Bulgaria

Croatia

Czech Republic

Denmark

Finland

France

FYR of Macedonia

Germany

Greece

Iceland

Ireland

Israel

Italy

Lithuania

Morocco

Netherlands

New Zealand

Poland

Portugal

Romania

Russian Federation

Serbia

Slovenia

Spain

Sweden

Switzerland

Turkey

Ukraine

United Kingdom

United States

Member area provided by LTFE
COST is supported by the EU Framework Programme Horizon 2020
This website is supported by COST
06/01/2015 (Added to site)
Author(s): Kranjc, M.; Markelc, B.; Bajd, F.; Cemazar, M.; Sersa, I.; Blagus, T; Miklavcic, D.

In situ monitoring of electric field distribution in mouse tumor during electroporation

Journal: Radiology, 274/1 (2015), pp. 115-123
DOI: 10.1148/radiol.14140311x
Request reprint  |  Tell your friend  | 

Abstract:

Purpose: To investigate the feasibility of magnetic resonance (MR) electric impedance tomography (EIT) technique for in situ monitoring of electric field distribution during in vivo electroporation of mouse tumors to predict reversibly electroporated tumor areas.

Material and methods: All experiments received institutional animal care and use committee approval. Group 1 consisted of eight tumors that were used for determination of predicted area of reversibly electroporated tumor cells with MR EIT by using a 2.35-T MR imager. In addition, T1-weighted images of tumors were acquired to determine entrapment of contrast agent within the reversibly electroporated area. A correlation between predicted reversible electroporated tumor areas as determined with MR EIT and areas of entrapped MR contrast agent was evaluated to verify the accuracy of the prediction. Group 2 consisted of seven tumors that were used for validation of radiologic imaging with histopathologic staining. Histologic analysis results were then compared with predicted reversible electroporated tumor areas from group 1. Results were analyzed with Pearson correlation analysis and one-way analysis of variance.

Results: Mean coverage +/- standard deviation of tumors with electric field that leads to reversible electroporation of tumor cells obtained with MR EIT (38% +/- 9) and mean fraction of tumors with entrapped MR contrast agent (41% +/- 13) were correlated (Pearson analysis, r = 0.956, P = .005) and were not statistically different (analysis of variance, P = .11) from mean fraction of tumors from group 2 with entrapped fluorescent dye (39% +/- 12).

Conclusion: MR EIT can be used for determining electric field distribution in situ during electroporation of tissue. Implementation of MR EIT in electroporation-based applications, such as electrochemotherapy and irreversible electroporation tissue ablation, would enable corrective interventions before the end of the procedure and would additionally improve the treatment outcome.


The paper is available via this link.



Project Office

Working groups

Steering Committee

Founding members

DC Rapporteurs

Related sites: